## Abstract In this review we discuss the limited efficacy for current pharmacological agents used in prophylaxis and treatment of thrombosis and highlight targeted delivery of antiβthrombotic agents to fibrin, platelets, red blood cells and endothelium. Β© 2011 IUBMB IUBMB Life, 2011
Clinical applications of new antithrombotic agents
β Scribed by R. J. R. Beijering; H. ten Cate; J. W. ten Cate
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 160 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Several technical advances over the years have allowed microsurgery to be successful. However, thrombosis, particularly at the anastomosis site, remains a complication of microvascular surgery. Various preventive measures, including drugs, have been used to improve microvascular surgica
In the quest to develop optimal antithrombotic therapies for reconstructive microsurgery, with concomitant minimization of patient risk for generalized hemorrhage, surgeons have been turning to localized intraarterial delivery of various agents. An extension of this direction is to design agents tha